Extended Data Fig. 8: PFS conditioned on baseline biomarker assessments. | Nature Medicine

Extended Data Fig. 8: PFS conditioned on baseline biomarker assessments.

From: Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial

Extended Data Fig. 8: PFS conditioned on baseline biomarker assessments.

The dashed vertical lines represent 6- and 12-month PFS. The dashed horizontal line represents the median. ccRCC, clear cell renal cell cancer; CI, confidence interval; NE, not evaluable; NR, not reached; PFS, progression-free survival; TGFβ, transforming growth factor-beta; Treg, regulatory T cell.

Back to article page